Xie Jian 4

What Happened

• Xie Jian, President and Chief Operating Officer of Fulgent Genetics (FLGT), had 4,361 shares disposed on July 26, 2026. The shares were withheld at a price of $19.67 per share, producing a value of $85,781. The transaction is reported as code F (shares withheld to satisfy tax withholding).

Key Details

• Transaction date and price: July 26, 2026 — 4,361 shares @ $19.67/share.
• Total value of shares withheld: $85,781.
• Filing date: July 28, 2026 (filed within the typical two-business-day Form 4 window — timely).
• Shares owned after the transaction: not specified in the provided filing summary.
• Footnotes:
  • F1: Shares were withheld to satisfy tax withholding upon vesting of restricted stock units assumed in the November 7, 2022 merger agreement; those awards were originally reported on Form 4 filed November 9, 2022.
  • F2: Some securities are held by The Hsieh Family Dynasty Trust; Mr. Xie serves on the trust's investment committee and disclaims beneficial interest except for any pecuniary interest.

Context

• This was a tax-withholding disposition (cashless withholding) tied to RSU vesting, a routine administrative transaction rather than an open-market sale that signals a change in insider sentiment. No options were exercised and no new purchases were reported.